Search all trials

Find therapies in clinical trials near you – page 50

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study of ibrutinib and venetoclax combination therapy for patients with relapsed or refractory chronic lymphocytic leukemia who have adequate kidney function

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Short-bowel syndrome

Not recruiting

InvestigationalNo placebo

Long-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome

InvestigationalNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Apraglutide

Contact Research Centre

Malignant melanoma stage III

Not recruiting

Registered drug

Study on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Chronic fatigue syndrome

Not recruiting

Registered drugNo placebo

Study of Daratumumab Injections for Patients with Moderate to Severe Chronic Fatigue Syndrome

Registered drugNo placebo

Norway

Participants:18–64 years
Substances:Daratumumab

Contact Research Centre

Prostate cancer metastatic

Not recruiting

Registered drugNo placebo

Study of enzalutamide alone versus enzalutamide with radium-223 combination in patients with bone metastatic castration-resistant prostate cancer with mild or no symptoms

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

Migraine

Not recruiting

Registered drug

Study on Botulinum Toxin Type A for Patients with Treatment-Resistant Chronic Migraine

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Endometrial cancer stage III+1

Not recruiting

Registered drug

Study on Dostarlimab, Carboplatin, and Paclitaxel for Patients with Recurrent or Advanced Endometrial Cancer

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Metastases to liver

Not recruiting

Registered drugNo placebo

Study on Treatment for Colorectal Liver Metastases Using Heparin, Dexamethasone, and Floxuridine for Patients with Heavy Tumor Burden

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Floxuridine

Contact Research Centre

Diffuse large B-cell lymphoma+2

Not recruiting

Registered drug

Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Apixaban

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study Comparing Idecabtagene Vicleucel and Lenalidomide Maintenance Therapy for Adults with Newly Diagnosed Multiple Myeloma After Stem Cell Transplant

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Atrial fibrillation+2

Not recruiting

Registered drug

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

Norway

Participants:18–64 years · 65+ years
Substances:Apixaban

Contact Research Centre

Find therapies in clinical trials near you – page 50

678 trials match your criteria

Chronic lymphocytic leukaemia

Study of ibrutinib and venetoclax combination therapy for patients with relapsed or refractory chronic lymphocytic leukemia who have adequate kidney function

Short-bowel syndrome

Long-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome

Malignant melanoma stage III

Study on Pembrolizumab for Patients with High-Risk Stage III Melanoma After Surgery

Chronic fatigue syndrome

Study of Daratumumab Injections for Patients with Moderate to Severe Chronic Fatigue Syndrome

Prostate cancer metastatic

Study of enzalutamide alone versus enzalutamide with radium-223 combination in patients with bone metastatic castration-resistant prostate cancer with mild or no symptoms

Migraine

Study on Botulinum Toxin Type A for Patients with Treatment-Resistant Chronic Migraine

Endometrial cancer stage III+1

Study on Dostarlimab, Carboplatin, and Paclitaxel for Patients with Recurrent or Advanced Endometrial Cancer

Metastases to liver

Study on Treatment for Colorectal Liver Metastases Using Heparin, Dexamethasone, and Floxuridine for Patients with Heavy Tumor Burden

Diffuse large B-cell lymphoma+2

Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

Plasma cell myeloma

Study Comparing Idecabtagene Vicleucel and Lenalidomide Maintenance Therapy for Adults with Newly Diagnosed Multiple Myeloma After Stem Cell Transplant

Chronic lymphocytic leukaemia

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Atrial fibrillation+2

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.